b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="bmcid" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2754485/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754485/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Infectious Diseases" /><meta name="citation_title" content="Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study" /><meta name="citation_authors" content="C\xc3\xa9dric Daubin, Jean-Jacques Parienti, Sabine Fradin, Astrid Vabret, Michel Ramakers, Nicolas Terzi, Fran\xc3\xa7ois Freymuth, Pierre Charbonneau, Damien du Cheyron" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="9" /><meta name="citation_firstpage" content="157" /><meta name="citation_doi" content="10.1186/1471-2334-9-157" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2754485/?report=abstract" /><meta name="citation_pmid" content="19772586" /><meta name="DC.Title" content="Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="C\xc3\xa9dric Daubin" /><meta name="DC.Contributor" content="Jean-Jacques Parienti" /><meta name="DC.Contributor" content="Sabine Fradin" /><meta name="DC.Contributor" content="Astrid Vabret" /><meta name="DC.Contributor" content="Michel Ramakers" /><meta name="DC.Contributor" content="Nicolas Terzi" /><meta name="DC.Contributor" content="Fran\xc3\xa7ois Freymuth" /><meta name="DC.Contributor" content="Pierre Charbonneau" /><meta name="DC.Contributor" content="Damien du Cheyron" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1186/1471-2334-9-157" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study" /><meta property="og:type" content="article" /><meta property="og:description" content="Serum procalcitonin (PCT) is considered useful in predicting the likeliness of developing bacterial infections in emergency setting. In this study, we describe PCT levels overtime and their relationship with bacterial infection in chronic obstructive ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754485/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-bmcid.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2754485/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2754485/pdf/1471-2334-9-157.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BA93FE9A3AF210000000004FC04FA.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/36/">BMC Infect Dis</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/175846/">v.9; 2009</a></li><li class="accid">PMC2754485</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-bmcid.png" alt="Logo of bmcid" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" alt="BioMed Central web site" coords="0,0,99,74" href="http://www.biomedcentral.com" target="pmc_ext" /><area shape="rect" coords="100,54,172,74" alt="this article" href="//dx.doi.org/10.1186/1471-2334-9-157" target="pmc_ext" /><area shape="rect" coords="173,54,223,74" alt="Search" href="https://bmcinfectdis.biomedcentral.com//search/bmcinfectdis" target="pmc_ext" /><area shape="rect" coords="224,55,342,74" alt="Manuscript submission" href="https://bmcinfectdis.biomedcentral.com//manuscript/bmcinfectdis" target="pmc_ext" /><area shape="rect" coords="343,53,480,74" alt="Registration" href="https://bmcinfectdis.biomedcentral.com//registration" target="pmc_ext" /><area shape="rect" coords="0,0,480,74" alt="Journal front page" href="https://bmcinfectdis.biomedcentral.com//bmcinfectdis" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Infect Dis</span>. 2009; 9: 157. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Sep 21. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2334-9-157" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2334-9-157</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2754485</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19772586">19772586</a></div></div></div></div><h1 class="content-title">Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Daubin%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A1" class="affpopup" co-rid="_co_idm140144720148176" co-class="co-affbox">C&#x000e9;dric Daubin</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup> <a href="/pubmed/?term=Parienti%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A2" class="affpopup" co-rid="_co_idm140144761796112" co-class="co-affbox">Jean-Jacques Parienti</a>,<sup>2</sup> <a href="/pubmed/?term=Fradin%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A3" class="affpopup" co-rid="_co_idm140144721953952" co-class="co-affbox">Sabine Fradin</a>,<sup>3</sup> <a href="/pubmed/?term=Vabret%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A4" class="affpopup" co-rid="_co_idm140144722516816" co-class="co-affbox">Astrid Vabret</a>,<sup>4</sup> <a href="/pubmed/?term=Ramakers%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A5" class="affpopup" co-rid="_co_idm140144678055840" co-class="co-affbox">Michel Ramakers</a>,<sup>1</sup> <a href="/pubmed/?term=Terzi%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A6" class="affpopup" co-rid="_co_idm140144750392384" co-class="co-affbox">Nicolas Terzi</a>,<sup>1</sup> <a href="/pubmed/?term=Freymuth%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A7" class="affpopup" co-rid="_co_idm140144721062352" co-class="co-affbox">Fran&#x000e7;ois Freymuth</a>,<sup>4</sup> <a href="/pubmed/?term=Charbonneau%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A8" class="affpopup" co-rid="_co_idm140144720146320" co-class="co-affbox">Pierre Charbonneau</a>,<sup>1</sup> and  <a href="/pubmed/?term=du%20Cheyron%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586" id="A9" class="affpopup" co-rid="_co_idm140144720150160" co-class="co-affbox">Damien du Cheyron</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140144720148176"><h3 class="no_margin">C&#x000e9;dric Daubin</h3><p><sup>1</sup>The Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Daubin%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">C&#x000e9;dric Daubin</a></div></div><div id="_co_idm140144761796112"><h3 class="no_margin">Jean-Jacques Parienti</h3><p><sup>2</sup>The Department of Infectious Diseases and Biostatistics and Clinical Research, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Parienti%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Jean-Jacques Parienti</a></div></div><div id="_co_idm140144721953952"><h3 class="no_margin">Sabine Fradin</h3><p><sup>3</sup>The Department of Biochemistry, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Fradin%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Sabine Fradin</a></div></div><div id="_co_idm140144722516816"><h3 class="no_margin">Astrid Vabret</h3><p><sup>4</sup>The Department of Virology, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Vabret%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Astrid Vabret</a></div></div><div id="_co_idm140144678055840"><h3 class="no_margin">Michel Ramakers</h3><p><sup>1</sup>The Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Ramakers%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Michel Ramakers</a></div></div><div id="_co_idm140144750392384"><h3 class="no_margin">Nicolas Terzi</h3><p><sup>1</sup>The Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Terzi%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Nicolas Terzi</a></div></div><div id="_co_idm140144721062352"><h3 class="no_margin">Fran&#x000e7;ois Freymuth</h3><p><sup>4</sup>The Department of Virology, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Freymuth%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Fran&#x000e7;ois Freymuth</a></div></div><div id="_co_idm140144720146320"><h3 class="no_margin">Pierre Charbonneau</h3><p><sup>1</sup>The Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=Charbonneau%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Pierre Charbonneau</a></div></div><div id="_co_idm140144720150160"><h3 class="no_margin">Damien du Cheyron</h3><p><sup>1</sup>The Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France</p><div>Find articles by <a href="/pubmed/?term=du%20Cheyron%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19772586">Damien du Cheyron</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140144750232240_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140144750232240_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140144750232240_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140144750232240_ai" style="display:none"><div class="fm-affl" lang="en" id="I1"><sup>1</sup>The Department of Medical Intensive Care, Caen University Hospital, 14033 Caen Cedex, France</div><div class="fm-affl" lang="en" id="I2"><sup>2</sup>The Department of Infectious Diseases and Biostatistics and Clinical Research, Caen University Hospital, 14033 Caen Cedex, France</div><div class="fm-affl" lang="en" id="I3"><sup>3</sup>The Department of Biochemistry, Caen University Hospital, 14033 Caen Cedex, France</div><div class="fm-affl" lang="en" id="I4"><sup>4</sup>The Department of Virology, Caen University Hospital, 14033 Caen Cedex, France</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><span class="contrib-email" id="A1">C&#x000e9;dric Daubin: <a href="mailto:dev@null" data-email="rf.neac-uhc@c-nibuad" class="oemail">rf.neac-uhc@c-nibuad</a>; </span> <span class="contrib-email" id="A2">Jean-Jacques Parienti: <a href="mailto:dev@null" data-email="rf.neac-uhc@jj-itneirap" class="oemail">rf.neac-uhc@jj-itneirap</a>; </span> <span class="contrib-email" id="A3">Sabine Fradin: <a href="mailto:dev@null" data-email="rf.neac-uhc@s-nidarf" class="oemail">rf.neac-uhc@s-nidarf</a>; </span> <span class="contrib-email" id="A4">Astrid Vabret: <a href="mailto:dev@null" data-email="rf.neac-uhc@a-terbav" class="oemail">rf.neac-uhc@a-terbav</a>; </span> <span class="contrib-email" id="A5">Michel Ramakers: <a href="mailto:dev@null" data-email="rf.neac-uhc@m-srekamar" class="oemail">rf.neac-uhc@m-srekamar</a>; </span> <span class="contrib-email" id="A6">Nicolas Terzi: <a href="mailto:dev@null" data-email="rf.neac-uhc@n-izret" class="oemail">rf.neac-uhc@n-izret</a>; </span> <span class="contrib-email" id="A7">Fran&#x000e7;ois Freymuth: <a href="mailto:dev@null" data-email="rf.neac-uhc@f-htumyerf" class="oemail">rf.neac-uhc@f-htumyerf</a>; </span> <span class="contrib-email" id="A8">Pierre Charbonneau: <a href="mailto:dev@null" data-email="rf.neac-uhc@p-uaennobrahc" class="oemail">rf.neac-uhc@p-uaennobrahc</a>; </span> <span class="contrib-email" id="A9">Damien du Cheyron: <a href="mailto:dev@null" data-email="rf.neac-uhc@d-noryehcud" class="oemail">rf.neac-uhc@d-noryehcud</a></span> </div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140144750232240_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Mar 19; Accepted 2009 Sep 21.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140144750232240_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9;2009 Daubin et al; licensee BioMed Central Ltd.</div><div class="license half_rhythm">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2754485/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140144796478016" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140144796478016title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Serum procalcitonin (PCT) is considered useful in predicting the likeliness of developing bacterial infections in emergency setting. In this study, we describe PCT levels overtime and their relationship with bacterial infection in chronic obstructive pulmonary disease (COPD) critically ill patients with pneumonia.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">We conducted a prospective cohort study in an ICU of a University Hospital. All consecutive COPD patients admitted for pneumonia between September 2005 and September 2006 were included. Respiratory samples were tested for the presence of bacteria and viruses. Procalcitonin was sequentially assessed and patients classified according to the probability of the presence of a bacterial infection.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Thirty four patients were included. The PCT levels were assessed in 32/34 patients, median values were: 0.493 &#x003bc;g/L [IQR, 0.131 to 1.471] at the time of admission, 0.724 &#x003bc;g/L [IQR, 0.167 to 2.646] at six hours, and 0.557 &#x003bc;g/L [IQR, 0.123 to 3.4] at 24 hours. The highest PCT (PCTmax) levels were less than 0.1 &#x003bc;g/L in 3/32 (9%) patients and greater than 0.25 &#x003bc;g/L in 22/32 (69%) patients, suggesting low and high probability of bacterial infection, respectively. Fifteen bacteria and five viruses were detected in 15/34 (44%) patients. Bacteria were not detected in patients with PCTmax levels &#x0003c; 0.1 &#x003bc;g/L. In contrast, bacteria were detected in 4/7 (57%) patients estimated unlikely to have a bacterial infection by PCT levels (PCTmax &#x0003e; 0.1 and &#x0003c; 0.25 &#x003bc;g/L).</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">Based on these results we suggest that a PCT level cut off &#x0003e; 0.1 &#x003bc;g/L may be more appropriate than 0.25 &#x003bc;g/L (previously proposed for non severe lower respiratory tract infection) to predict the probability of a bacterial infection in severe COPD patients with pneumonia. Further studies testing procalcitonin-based antibiotic strategies are needed in COPD patients with severe pneumonia.</p></div></div></div><div id="__sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec5title">Background</h2><p id="__p5" class="p p-first">Severe pneumonia is a common cause of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845005605">1</a>]. In this setting, a prompt initiation of antibiotics is recommended [<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461283">2</a>,<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461281">3</a>]. However, bacterial etiology is only found in approximately 50% of cases [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845005604">1</a>,<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461263">4</a>]. Other pathogens, such as respiratory viruses, have been reported in severe AECOPD requiring ventilation [<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845005601">5</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461277">6</a>] and pneumonic AECOPD [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845005602">1</a>]. Moreover, in clinical practice, signs and symptoms of bacterial and viral lower respiratory tract infections widely overlap [<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461261">7</a>].</p><p id="__p6" class="p p-last">Procalcitonin (PCT) has been described as a marker of bacterial infection [<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461250">8</a>] and thus may help physicians to limit inadequate use of antibiotics [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461265">9</a>-<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461249">11</a>]. We previously investigated the use of PCT in patients with AECOPD, without pneumonia, hospitalized in the ICU [<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461275">12</a>]. In this study, we assessed PCT levels overtime and their relationship with bacterial infection in chronic obstructive pulmonary disease (COPD) patients admitted to the ICU with severe pneumonia. In addition, we examined whether PCT thresholds predicting probability of bacterial infection previously reported [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461287">9</a>-<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461285">11</a>] could be efficient in this specific population.</p></div><div id="__sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec6title">Methods</h2><div id="__sec7" class="sec sec-first"><h3 id="__sec7title">Patients</h3><p id="__p7" class="p p-first-last">We conducted a monocentric prospective cohort study. All consecutive COPD patients with suspected lower respiratory tract infection admitted to the medical intensive care unit of the University Hospital of Caen between September 2005 and September 2006 were assessed for eligibility. Only those with infiltrates present on initial chest radiographs at admission to ICU and suspected for acute community-acquired pneumonia were included.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Definition</h3><p id="__p8" class="p p-first-last">We defined COPD according to the Global Initiative for Chronic Obstructive Lung Disease Guidelines (GOLD) 2005 <a href="http://www.goldcopd.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.goldcopd.com</a>. Pneumonic AECOPD was defined as a new infiltrate on chest radiograph with features of lower respiratory tract infection in COPD patients [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845005606">1</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461274">11</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461269">12</a>]. We used the pneumonia severity index (PSI) to estimate severity [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461260">13</a>]. A systematic search for bacteria with standard methods and for viruses with sensitive methods (i.e., PCR and RT-PCR methods), as reported elsewhere [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461259">6</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461266">12</a>,<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845005603">14</a>-<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320205311">16</a>] were performed. Briefly, sputum or tracheal aspirates were bacteriologically processed if less than 1% of the observed field contained squamous epithelial cells and more than 25 neutrophils were observed [<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461280">17</a>]. Pneumonia was considered bacteriologically confirmed when at least one of the following criteria were present: pathogen concentration greater than 10<sup>5 </sup>cfu/mL in tracheobronchial aspirations or sputum samples; blood culture positive for a bacterial pathogen in the absence of an extrapulmonary focus [<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461252">17</a>-<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_320205310">19</a>]. In addition, a serological diagnostic for antibodies to Legionella pneumophila was performed by indirect immunofluorescence, associated with a detection of Legionella pneumophila serogroup 1 antigen in urine samples in all patients.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Study design</h3><p id="__p9" class="p p-first-last">The ethical board decided approval was not necessary given the observational nature of the study. Accordingly, no informed consent was obtained from the patients. At baseline, COPD severity, according to GOLD criteria, other comorbidities, and clinical and biological variables were recorded [<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461276">12</a>]. All patients were treated according to the recommendations of the French Consensus Conference [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461258">3</a>] (i.e., an antibiotic treatment is recommended in severe pneumonia and severe exacerbation of COPD patients requiring admission in ICU).</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">Measurement of serum procalcitonin</h3><p id="__p10" class="p p-first-last">Procalcitonin (PCT) assessment followed standard methods described elsewhere [<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461291">12</a>]. The circulating levels of PCT were sequentially assessed at ICU admission (PCT-H0), after six hours (PCT-H6), and after twenty fours (PCT-H24) hours in ICU. All blood samples were analyzed at the end of the study period. PCT was measured using a sensitive immunoassay (Kryptor PCT, Brahms, Hennigsdorf, Germany) with a functional assay sensitivity of 0.06 &#x003bc;g/L, about fourfold above mean normal levels [<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461270">20</a>]. Patients were classified into three groups based on probability of bacterial infection according to the highest procalcitonin level measured (PCTmax). As previously reported [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461286">9</a>-<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461288">11</a>], the groups were: group 1, PCTmax &#x0003c; 0.1 &#x003bc;g/L indicating an a low probability of a bacterial infection; group 2, PCTmax &#x0003e; 0.1 and &#x0003c; 0.25 &#x003bc;g/L indicating an unlikely or possible bacterial infection infection; and group 3, PCTmax &#x0003e; 0.25 &#x003bc;g/L indicating a high probability of bacterial infection.</p></div><div id="__sec11" class="sec sec-last"><h3 id="__sec11title">Statistical analysis</h3><p id="__p11" class="p p-first-last">Quantitative and qualitative data were expressed as means (+/- SD), or median (interquartile range, IQR) and percentage (with their 95% confidence intervals (CI) based on normal approximation), respectively. Categorical variables were compared using the chi-square or Fischer\'s exact test, as appropriate. Quantitative variables were compared using the Student <em>t</em>-test or the Mann-Whitney non parametric test, as appropriate. The level of significance was set at 0.05 and all tests were two-sided. We used EPI-INFO version 6.04 dfr (EPI-INFO, CDC, Atlanta, GA) for data collection, and EPI-INFO and SAS version 9.1 (SAS Institute Inc, Cary, NC) for data analysis.</p></div></div><div id="__sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec12title">Results</h2><div id="__sec13" class="sec sec-first"><h3 id="__sec13title">Patients and baseline characteristics</h3><p id="__p12" class="p p-first">During the study period, 80 COPD patients with suspected lower respiratory tract infection were admitted to the ICU, 34 had pneumonia. Baseline characteristics of the pneumonic AECOPD patients are shown in Table <a href="/pmc/articles/PMC2754485/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1.</span></span><span>1</span></a>. Twenty three patients (68%) had severe or very severe COPD. During the previous 30-day period, antibiotic or oral steroid therapy for exacerbations of COPD was reported by 7 and 8 patients, respectively. Eleven patients had received antibiotics within the 24 hours preceding ICU admission. With the exception of 4 patients, all had a severe pneumonia (PSI class IV and V). All patients required ventilator support: non invasive ventilation (NIV) in 23 (68%) patients and invasive mechanical ventilation in 20 (58%) patients, 9 of whom received invasive mechanical ventilation after NIV failure. All patients received antibiotics and inhaled steroids and 18 (53%) systemic steroids. The mean length of ICU stay was 29 &#x000b1; 31 days. The mean length of non-invasive ventilation, invasive mechanical ventilation, and ventilation-free days during the ICU stay were 2.85 &#x000b1; 5.1 days, 17.8 &#x000b1; 31.1 days, and 2.56 &#x000b1; 2.34 days, respectively. Fourteen patients developed septic shock, nine during the first hours following ICU admission and five during their ICU stay. Six patients developed ventilator-associated pneumonia. Twenty two patients were discharged from the hospital. Twelve patients died, eight from septic shock, three from COPD-related respiratory failure, and one from malignant bronchospasm complicated with cardiac arrest.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p13">Baseline characteristics of all patients and according to the maximum procalcitonin levels measured (PCTmax)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140144720434288" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">All<br /><strong>n = 34</strong>*</th><th align="center" rowspan="1" colspan="1">PCT&#x0003c;0.1<br />n = 3</th><th align="center" rowspan="1" colspan="1">0.1&#x0003c;PCT&#x0003c;0.25<br />n = 7</th><th align="center" rowspan="1" colspan="1">PCT&#x0003e;0.25<br />n = 22</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, yr</td><td align="center" rowspan="1" colspan="1">70 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1">71 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1">71 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1">69 &#x000b1; 10</td></tr><tr><td align="left" rowspan="1" colspan="1">Male sex, no.(%)</td><td align="center" rowspan="1" colspan="1">28(82)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">6(86)</td><td align="center" rowspan="1" colspan="1">18(82)</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">SAPS II score</td><td align="center" rowspan="1" colspan="1">37 [20-50]</td><td align="center" rowspan="1" colspan="1">27 [23-30]</td><td align="center" rowspan="1" colspan="1">31 [24-44]</td><td align="center" rowspan="1" colspan="1">40 [34-62]</td></tr><tr><td align="left" rowspan="1" colspan="1">LOD score</td><td align="center" rowspan="1" colspan="1">6 [4-10]</td><td align="center" rowspan="1" colspan="1">6 [4-10]</td><td align="center" rowspan="1" colspan="1">6 [411]</td><td align="center" rowspan="1" colspan="1">6 [4-10]</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities, no (%)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Current smokers,</td><td align="center" rowspan="1" colspan="1">11(32)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4(57)</td><td align="center" rowspan="1" colspan="1">7(32)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Chronic alcohol abuse</td><td align="center" rowspan="1" colspan="1">8(24)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">1(14)</td><td align="center" rowspan="1" colspan="1">4(18)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Obesity</td><td align="center" rowspan="1" colspan="1">12(35)</td><td align="center" rowspan="1" colspan="1">3(100)</td><td align="center" rowspan="1" colspan="1">2(29)</td><td align="center" rowspan="1" colspan="1">5(23)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Coronary artery disease</td><td align="center" rowspan="1" colspan="1">14(41)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">3(43)</td><td align="center" rowspan="1" colspan="1">9(41)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hypertensive heart disease</td><td align="center" rowspan="1" colspan="1">17(50)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">2(29)</td><td align="center" rowspan="1" colspan="1">12(55)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Congestive heart disease</td><td align="center" rowspan="1" colspan="1">9(26)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">8(36)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">13(38)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3(43)</td><td align="center" rowspan="1" colspan="1">8(36)</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic pseudomonas colonisation, no (%)</td><td align="center" rowspan="1" colspan="1">4(12)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(29)</td><td align="center" rowspan="1" colspan="1">2(9)</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Antibiotics in 24 H prior ICU admission<sup>&#x000b6;</sup>, no (%)</td><td align="center" rowspan="1" colspan="1">11(32)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(29)</td><td align="center" rowspan="1" colspan="1">8(36)</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">During the previous 30-day period<sup>&#x000b6;&#x000b6;</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Antibiotics for AECOPD</td><td align="center" rowspan="1" colspan="1">7(20)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(29)</td><td align="center" rowspan="1" colspan="1">5(23)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Oral steroid therapy for AECOPD</td><td align="center" rowspan="1" colspan="1">8(24)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">3(43)</td><td align="center" rowspan="1" colspan="1">5(23)</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Severity of COPD, no (%)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;GOLD stage I (mild)</td><td align="center" rowspan="1" colspan="1">2(6)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2(9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;GOLD stage II (moderate)</td><td align="center" rowspan="1" colspan="1">9(26)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">6(27)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;GOLD stage III (sever)</td><td align="center" rowspan="1" colspan="1">3(9)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3(14)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;GOLD stage IV (very sever)</td><td align="center" rowspan="1" colspan="1">20(59)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">7(100)</td><td align="center" rowspan="1" colspan="1">11(50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Home oxygen, no (%)</td><td align="center" rowspan="1" colspan="1">18(53)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">5(71)</td><td align="center" rowspan="1" colspan="1">11(50)</td></tr><tr><td align="left" rowspan="1" colspan="1">Home non-invasive ventilation, no (%)</td><td align="center" rowspan="1" colspan="1">6(18)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">2(28)</td><td align="center" rowspan="1" colspan="1">3(14)</td></tr><tr><td align="left" rowspan="1" colspan="1">Oral or inhaled steroid, no (%)</td><td align="center" rowspan="1" colspan="1">19(56)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">6(85)</td><td align="center" rowspan="1" colspan="1">10(45)</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Examination at ICU admission, no (%)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Dyspnea</td><td align="center" rowspan="1" colspan="1">34(100)</td><td align="center" rowspan="1" colspan="1">3(100)</td><td align="center" rowspan="1" colspan="1">7(100)</td><td align="center" rowspan="1" colspan="1">22(100)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Cough</td><td align="center" rowspan="1" colspan="1">11(32)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">3(43)</td><td align="center" rowspan="1" colspan="1">7(32)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Sputum</td><td align="center" rowspan="1" colspan="1">16(47)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">3(43)</td><td align="center" rowspan="1" colspan="1">11(50)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Rales</td><td align="center" rowspan="1" colspan="1">15(44)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">1(14)</td><td align="center" rowspan="1" colspan="1">12(55)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Wheezing</td><td align="center" rowspan="1" colspan="1">16(47)</td><td align="center" rowspan="1" colspan="1">2(66)</td><td align="center" rowspan="1" colspan="1">6(86)</td><td align="center" rowspan="1" colspan="1">7(32)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Body temperature, &#x000b0;C</td><td align="center" rowspan="1" colspan="1">37.3 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">37.0 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">36.5 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">37.7 &#x000b1; 1.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Leucocytes count (&#x000d7;10<sup>9</sup>/L)</td><td align="center" rowspan="1" colspan="1">13.7 &#x000b1; 6.4</td><td align="center" rowspan="1" colspan="1">11.2 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">12.5 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">14.9 &#x000b1; 7.4</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Pneumonia severity index (PSI)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PSI I, II, III</td><td align="center" rowspan="1" colspan="1">4(11)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">2(28)</td><td align="center" rowspan="1" colspan="1">1(5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PSI IV</td><td align="center" rowspan="1" colspan="1">14(42)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">4(57)</td><td align="center" rowspan="1" colspan="1">8(36)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PSI V</td><td align="center" rowspan="1" colspan="1">16(47)</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">1(14)</td><td align="center" rowspan="1" colspan="1">13(59)</td></tr></tbody></table></div><div id="largeobj_idm140144720434288" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2754485/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p14">Values are given as No.(%), median [25%-75% interquartile range], or mean &#x000b1; standard deviation</p><p id="__p15">* Levels of procalcitonin (PCT) were assessed in 32/34 patients. PCT is given in &#x003bc;g/L</p><p id="__p16"><sup>&#x000b6; </sup>One patient receiving antibiotic in 24 h prior ICU was not assessed for PCT levels</p><p id="__p17"><sup>&#x000b6;&#x000b6; </sup>Patients treated with antibiotic or oral steroid during the previous 30-day period for exacerbation of COPD were exclusive of those receiving antibiotic in 24 h prior ICU</p></div></div></div><div id="__sec14" class="sec"><h3 id="__sec14title">PCT measurements and clinical correlates</h3><p id="__p18" class="p p-first">The median [25%-75% IQR] PCT levels were as follows: at admission PCT-H0 was 0.493 &#x003bc;g/L [0.131-1.471], PCT-H6 was 0.724 &#x003bc;g/L [0.167-2.646], and PCT-H24 was 0.557 &#x003bc;g/L [0.123-3.4].</p><p id="__p19">PCT levels were not different in patients who had received antibiotics within the month or 24 hours prior to ICU admission, compared to antibiotic-naive patients (PCT-H0 0.695 &#x003bc;g/L [0.202-1.139] vs 0.470 &#x003bc;g/L [0.088-1.471], <em>p </em>= 0.73 and PCT-H0 0.942 &#x003bc;g/L [0.202-22.110] vs 0.438 &#x003bc;g/L [0.088-0.902], <em>p </em>= 0.22, respectively). In addition, steroids prior to ICU admission did not influence PCT levels (p = 0.76). PCT-H0 was significantly higher when abnormal breath sounds or rales were present (PCT-H0 1.661 &#x003bc;g/L [0.745-26.83] vs 0.207 &#x003bc;g/L [0.086-0.470], <em>p </em>= 0.0005) and when fever &#x0003e; 38&#x000b0;C was present; PCT-H0 1.495 &#x003bc;g/L [0.828-56.48] vs 0.272 &#x003bc;g/L [0.087-0.902], <em>p </em>= 0.0.05). No association was found between PCT-H0 levels and the presence or absence of sputum and cough.</p><p id="__p20" class="p p-last">The PCTmax was &#x0003c; 0.1 &#x003bc;g/L in 3/32 patients (9%), between 0.1 and 0.25 &#x003bc;g/L in 7/32 patients (22%), and &#x0003e; 0.25 &#x003bc;g/L in 22/32 patients (69%), including 20 patients with PCTmax &#x0003e; 0.5 &#x003bc;g/L. There were no associations between PCTmax levels &#x0003e; 0.25 &#x003bc;g/L and severity of COPD (<em>p </em>= 0.21), Simplified Acute Physiology Score type II (SAPSII) (<em>p </em>= 0.15), Logistic Organ Dysfonction (LOD) (<em>p </em>= 0.29), and PSI (<em>p </em>= 0.08).</p></div><div id="__sec15" class="sec sec-last"><h3 id="__sec15title">PCTmax levels and bacterial findings</h3><p id="__p21" class="p p-first">Figure <a href="/pmc/articles/PMC2754485/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1</span></span><span>1</span></a> depicts bacterial findings according to PCTmax levels. The dynamics of PCT measurements and bacterial findings are shown Figure <a href="/pmc/articles/PMC2754485/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2.</span></span><span>2</span></a>. Fifteen (44%) patients had microbiologically-confirmed pneumonia. Fifteen bacteria (4 <em>Pseudomonas aeruginosa</em>, 3 <em>Haemophilus influenzae</em>, 3 <em>Streptoccocus species</em>, 3 <em>Methicillin-resistant Staphyloccocus aureus</em>, 1 <em>Serratia species</em>, and 1 <em>Fusibacterium nucleatum</em>) and 5 viruses (3 rhinovirus, 1 human metapneumovirus, and 1 respiratory syncitial virus) were detected. A co-infection was detected in 3 cases (rhinovirus and <em>Streptoccocus</em>, rhinovirus and <em>Haemophilus influenzae</em>, and rhinovirus and <em>Fusibacterium nucleatum</em>). Seven patients cross over between PCT groups over time (Figure <a href="/pmc/articles/PMC2754485/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). No bacteria were detected in patients with PCTmax level &#x0003c; 0.1 &#x003bc;g/L. In contrast, bacteria were detected in more than half the patients estimated to have an unlikely bacterial infection (PCTmax &#x0003e; 0.1 and &#x0003c; 0.25 &#x003bc;g/L).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2754485/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140144722061296" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1471-2334-9-157-1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 1471-2334-9-157-1.jpg" src="/pmc/articles/PMC2754485/bin/1471-2334-9-157-1.jpg" /></div><div id="largeobj_idm140144722061296" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2754485/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2754485/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p22"><strong>Distribution of the highest procalcitonin level measurements (PCTmax) and microorganism findings in chronic obstructive pulmonary disease (COPD) patients with pneumonia</strong>. Also shown is the probability of bacterial infection according to procalcitonin (PCT) levels, as previously reported by Christ-Crain (11). * Procalcitonin (PCT) levels were not assessed in 2 patients. ** One patient receiving antibiotic in 24 h prior ICU was not assessed for PCT levels.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2754485/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140144748480672" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1471-2334-9-157-2.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 1471-2334-9-157-2.jpg" src="/pmc/articles/PMC2754485/bin/1471-2334-9-157-2.jpg" /></div><div id="largeobj_idm140144748480672" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2754485/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2754485/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p23"><strong>Dynamics of PCT measurements and bacterial findings</strong>. * Procalcitonin (PCT) levels were not assessed in 2 patients. ** A bacterial co-infection was detected in 2 patients.</p></div></div></div></div></div><div id="__sec16" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec16title">Discussion</h2><p id="__p24" class="p p-first">Our study examined microbiological findings and PCT levels in critically ill COPD patients admitted for pneumonia. To our knowledge, this has not been addressed in the specific setting of the ICU. In agreement with previous report [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461251">11</a>], PCT level &#x0003c; 0.1 &#x003bc;g/L could indicate a low probability of bacterial infection in approximately 10% of patients (3/32). In contrast, bacteria were detected in more than half the patients (4/7) with PCT levels suggesting an unlikely or possible bacterial infection (PCTmax between 0.1 and 0.25 &#x003bc;g/L), as previously defined outside the ICU [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461256">9</a>-<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461289">11</a>]. Therefore, a PCT cut off below 0.25 &#x003bc;g/L for antibiotic use may not be appropriate for severe pneumonia patients with COPD admitted to the ICU.</p><p id="__p25">We found a median PCT level of 0.493 &#x003bc;g/L [0.131-1.471] in COPD patients admitted to the ICU for pneumonia, this finding is consistent with previous studies focusing on community-acquired pneumonia (CAP) [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461273">11</a>,<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461290">21</a>]. However, in these two large prospective cohorts focusing on CAP, less than 25% of patients had COPD and less than 10% were admitted to the ICU. In previous reports, PCT levels were not different between patients pre-treated with antibiotics and antibiotic-naive patients [<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461268">10</a>,<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461279">11</a>], a finding confirmed by our study. In contrast to previous reports, we found an association between PCT levels and clinical symptoms (fever and abnormal breath sounds or rales).</p><p id="__p26">The distribution of patients according to PCTmax levels (ie &#x0003c; 0.1 &#x003bc;g/L, 0.1 to 0.25 &#x003bc;g/L, and &#x0003e; 0.25 &#x003bc;g/L) was similar to that previously reported by Christ-Crain et al [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461262">11</a>]. In patients (10%) with PCTmax levels &#x0003c; 0.1 &#x003bc;g/L, bacteria were not detected, suggesting antibiotics may be unnecessary in this subgroup. In contrast, bacteria were detected in more than half the patients with PCT levels suggesting an unlikely or possible bacterial infection (PCTmax &#x0003e; 0.1 and &#x0003c; 0.25 &#x003bc;g/L). This result suggests a PCT level cut-off &#x0003e; 0.1 &#x003bc;g/L, rather than &#x0003e; 0.25 &#x003bc;g/L (proposed for non severe pneumonia [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461255">11</a>]), may be more appropriate for initiating antibiotics in a PCT based antibiotic strategy in critically ill COPD patients with pneumonia. Such a study, however, remains to be conducted.</p><p id="__p27">In addition, this study confirms the importance of a sequential PCT levels assessment to predict probability of bacterial infection specifically when the first measurement is low (i.e., PCT &#x0003c; 0.1 &#x003bc;g/L). Indeed, three from five patients crossing over from PCT group &#x0003c; 0.1 &#x003bc;g/L to PCT group 0.1-0.25 &#x003bc;g/L over time, had bacteriologically documented pneumonia. This point should have important implications for furthers studies assessing procalcitonin-based antibiotic strategies in this setting.</p><p id="__p28" class="p p-last">We are aware of the limitations of our study, which include the monocentric design and small sample size. In addition, a prior ICU admission antibiotic treatment in a subset of patients may have affected the results of microbiological examinations. However, all patients pre-treated with antibiotics had PCT levels higher than 0.25 &#x003bc;g/L (except two in PCT group 0.1-0.25 &#x003bc;g/L) indicating a high probability of the presence of bacterial infection. Strengths of the study include the dynamic measurement of PCT along with the systematic search for bacteria in a specific population. For this reason, we believe this study adds useful information about PCT levels in COPD patients with severe pneumonia requiring admission to ICU and the likelihood of bacterial infection.</p></div><div id="__sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec17title">Conclusion</h2><p id="__p29" class="p p-first-last">This study reports that less than 10% of COPD patients suspected of severe pneumonia had PCT levels lower than 0.1 &#x003bc;g/L suggesting a low probability of a bacterial infection and that a subset of patient with PCT levels between 0.1 and 0.25 &#x003bc;g/L (range previously reported as indicating an unlikely or possible bacterial infection [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461271">9</a>-<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461282">11</a>]) had a documented bacterial infection. Based on these results we hypothesize that a PCT level cut off &#x0003e; 0.1 &#x003bc;g/L may be more appropriate than 0.25 (previously proposed for non severe lower respiratory tract infection [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461284">9</a>-<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_169461257">11</a>] to predict the probability of a bacterial infection in severe COPD patients with pneumonia in a procalcitonin-based antibiotic strategy. However, in clinical practice, a such procalcitonin-based antibiotic strategy using the PCT threshold of 0.1 &#x003bc;g/L should have only a limited impact on the decision to initiate antibiotics in this setting. Further studies are necessary to assess the capability of procalcitonin guidance to shorten antibiotic duration in critically ill COPD patients with pneumonia.</p></div><div id="__sec18" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec18title">Abbreviations</h2><p id="__p30" class="p p-first-last">AECOPD: acute exacerbation of chronic obstructive pulmonary disease; APACHE II: acute physiology and chronic health evaluation type II; ICU: medical intensive care unit; LOD: logistic organ dysfunction system; PCR: polymerase chain reaction; PSI: pneumonia severity index; SAPS II: simplified acute physiology score II.</p></div><div id="__sec19" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec19title">Competing interests</h2><p id="__p31" class="p p-first-last">The authors declare that they have no competing interests.</p></div><div id="__sec20" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec20title">Authors\' contributions</h2><p id="__p32" class="p p-first-last">CD and MR initiated the study, the design, and the experimental protocol. SF performed the PCT measurements. AV and FF performed the virologic assessments. CD and JJP performed the statistical analysis and were involved in the interpretation of the results. CD wrote the manuscript, and JJP, MR, and DDC helped to draft the manuscript. DDC, MR, NT, and PC contributed to the conception and design of the study and revision of the manuscript. All authors read and approved the final manuscript.</p></div><div id="__sec21" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec21title">Pre-publication history</h2><p id="__p33" class="p p-first">The pre-publication history for this paper can be accessed here:</p><p id="__p34" class="p p-last"><a href="http://www.biomedcentral.com/1471-2334/9/157/prepub" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.biomedcentral.com/1471-2334/9/157/prepub</a></p></div><div id="__sec22" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="__sec22title">Acknowledgements</h2><!--/article/back/sec/--><p id="__p35" class="p p-first-last">The authors want to thank the nursing staff of the Lemi&#x000e8;re and Babinski units for their important contributions during the conduction of this study. The authors thank BRAHMS (the manufacturer of procalcitonin assay) for providing assay materials. This study was funded by an academic unrestricted grant from the Caen C&#x000f4;te de Nacre University hospital.</p></div><div id="idm140144750492240" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140144750492240title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="mixed-citation">Lieberman D, Lieberman D, Gelfer Y, Varshavsky R, Dvoskin B, Leinonen M, Friedman MG. Pneumonic vs nonpneumonic acute exacerbations of COPD. <span><span class="ref-journal">Chest. </span>2002;<span class="ref-vol">122</span>:1264\xe2\x80\x9370. doi: 10.1378/chest.122.4.1264.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7094389/">PMC free article</a>]</span> [<a href="/pubmed/12377851" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.122.4.1264" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Pneumonic+vs+nonpneumonic+acute+exacerbations+of+COPD&amp;author=D+Lieberman&amp;author=D+Lieberman&amp;author=Y+Gelfer&amp;author=R+Varshavsky&amp;author=B+Dvoskin&amp;volume=122&amp;publication_year=2002&amp;pages=1264-70&amp;pmid=12377851&amp;doi=10.1378/chest.122.4.1264&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="mixed-citation">Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, Heijden G van der, Verheij TJ. European Respiratory Society. Guidelines for the management of adult lower respiratory tract infections. <span><span class="ref-journal">Eur Respir J. </span>2005;<span class="ref-vol">26</span>:1138\xe2\x80\x931180. doi: 10.1183/09031936.05.00055705.</span> [<a href="/pubmed/16319346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.05.00055705" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Guidelines+for+the+management+of+adult+lower+respiratory+tract+infections&amp;author=M+Woodhead&amp;author=F+Blasi&amp;author=S+Ewig&amp;author=G+Huchon&amp;author=M+Ieven&amp;volume=26&amp;publication_year=2005&amp;pages=1138-1180&amp;pmid=16319346&amp;doi=10.1183/09031936.05.00055705&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="mixed-citation">Soci&#x000e9;t&#x000e9; de Pathologie Infectieuse de Langue Fran&#x000e7;aise. [15th consensus conference about management of lower respiratory tract infections in immunocompetent adult] <span><span class="ref-journal">Med Mal Infect. </span>2006;<span class="ref-vol">36</span>:235\xe2\x80\x93244.</span> [<a href="/pubmed/16967525" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Mal+Infect&amp;title=[15th+consensus+conference+about+management+of+lower+respiratory+tract+infections+in+immunocompetent+adult]&amp;volume=36&amp;publication_year=2006&amp;pages=235-244&amp;pmid=16967525&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="mixed-citation">Torres A, Dorca J, Zalaca&#x000ed;n R, Bello S, El-Ebiary M, Molinos L, Ar&#x000e9;valo M, Blanquer J, Celis R, Iriberri M, Prats E, Fern&#x000e1;ndez R, Irigaray R, Serra J. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>1996;<span class="ref-vol">154</span>:1456\xe2\x80\x9361.</span> [<a href="/pubmed/8912764" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Community-acquired+pneumonia+in+chronic+obstructive+pulmonary+disease:+a+Spanish+multicenter+study&amp;author=A+Torres&amp;author=J+Dorca&amp;author=R+Zalaca&#x000ed;n&amp;author=S+Bello&amp;author=M+El-Ebiary&amp;volume=154&amp;publication_year=1996&amp;pages=1456-61&amp;pmid=8912764&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B5"><span class="mixed-citation">Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. <span><span class="ref-journal">Intensive Care Med. </span>2006;<span class="ref-vol">32</span>:1022\xe2\x80\x931029. doi: 10.1007/s00134-006-0202-x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7080063/">PMC free article</a>]</span> [<a href="/pubmed/16791664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00134-006-0202-x" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=Virus+infection+in+exacerbations+of+chronic+obstructive+pulmonary+disease+requiring+ventilation&amp;author=RJ+Cameron&amp;author=D+de+Wit&amp;author=TN+Welsh&amp;author=J+Ferguson&amp;author=TV+Grissell&amp;volume=32&amp;publication_year=2006&amp;pages=1022-1029&amp;pmid=16791664&amp;doi=10.1007/s00134-006-0202-x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="mixed-citation">Daubin C, Parienti JJ, Vincent S, Vabret A, du Cheyron D, Ramakers M, Freymuth F, Charbonneau P. Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study. <span><span class="ref-journal">Crit Care. </span>2006;<span class="ref-vol">10</span>:R142. doi: 10.1186/cc5059.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1751045/">PMC free article</a>]</span> [<a href="/pubmed/17022805" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2Fcc5059" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care&amp;title=Epidemiology+and+clinical+outcome+of+virus-positive+respiratory+samples+in+ventilated+patients:+a+prospective+cohort+study&amp;author=C+Daubin&amp;author=JJ+Parienti&amp;author=S+Vincent&amp;author=A+Vabret&amp;author=D+du+Cheyron&amp;volume=10&amp;publication_year=2006&amp;pages=R142&amp;pmid=17022805&amp;doi=10.1186/cc5059&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="mixed-citation">Halm EA, Teirstein AS. Clinical practice. Management of community-acquired pneumonia. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>:2039\xe2\x80\x9345. doi: 10.1056/NEJMcp020499.</span> [<a href="/pubmed/12490686" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMcp020499" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Clinical+practice.+Management+of+community-acquired+pneumonia&amp;author=EA+Halm&amp;author=AS+Teirstein&amp;volume=347&amp;publication_year=2002&amp;pages=2039-45&amp;pmid=12490686&amp;doi=10.1056/NEJMcp020499&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="mixed-citation">Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. <span><span class="ref-journal">Clin Infect Dis. </span>2004;<span class="ref-vol">39</span>:206\xe2\x80\x93217. doi: 10.1086/421997.</span> [<a href="/pubmed/15307030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F421997" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Serum+procalcitonin+and+C-reactive+protein+levels+as+markers+of+bacterial+infection:+a+systematic+review+and+meta-analysis&amp;author=L+Simon&amp;author=F+Gauvin&amp;author=DK+Amre&amp;author=P+Saint-Louis&amp;author=J+Lacroix&amp;volume=39&amp;publication_year=2004&amp;pages=206-217&amp;pmid=15307030&amp;doi=10.1086/421997&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="mixed-citation">Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, M&#x000fc;ller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. <span><span class="ref-journal">Lancet. </span>2004;<span class="ref-vol">363</span>:600\xe2\x80\x93607. doi: 10.1016/S0140-6736(04)15591-8.</span> [<a href="/pubmed/14987884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(04)15591-8" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect+of+procalcitonin-guided+treatment+on+antibiotic+use+and+outcome+in+lower+respiratory+tract+infections:+cluster-randomised,+single-blinded+intervention+trial&amp;author=M+Christ-Crain&amp;author=D+Jaccard-Stolz&amp;author=R+Bingisser&amp;author=MM+Gencay&amp;author=PR+Huber&amp;volume=363&amp;publication_year=2004&amp;pages=600-607&amp;pmid=14987884&amp;doi=10.1016/S0140-6736(04)15591-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="mixed-citation">Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, M&#x000fc;ller C, Huber P, M&#x000fc;ller B, Tamm M. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. <span><span class="ref-journal">Chest. </span>2007;<span class="ref-vol">131</span>:9\xe2\x80\x9319. doi: 10.1378/chest.06-1500.</span> [<a href="/pubmed/17218551" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.06-1500" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Antibiotic+treatment+of+exacerbations+of+COPD:+a+randomized,+controlled+trial+comparing+procalcitonin-guidance+with+standard+therapy&amp;author=D+Stolz&amp;author=M+Christ-Crain&amp;author=R+Bingisser&amp;author=J+Leuppi&amp;author=D+Miedinger&amp;volume=131&amp;publication_year=2007&amp;pages=9-19&amp;pmid=17218551&amp;doi=10.1378/chest.06-1500&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B11"><span class="mixed-citation">Christ-Crain M, Stolz D, Bingisser R, M&#x000fc;ller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, M&#x000fc;ller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2006;<span class="ref-vol">174</span>:84\xe2\x80\x9393. doi: 10.1164/rccm.200512-1922OC.</span> [<a href="/pubmed/16603606" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200512-1922OC" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Procalcitonin+guidance+of+antibiotic+therapy+in+community-acquired+pneumonia:+a+randomized+trial&amp;author=M+Christ-Crain&amp;author=D+Stolz&amp;author=R+Bingisser&amp;author=C+M&#x000fc;ller&amp;author=D+Miedinger&amp;volume=174&amp;publication_year=2006&amp;pages=84-93&amp;pmid=16603606&amp;doi=10.1164/rccm.200512-1922OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="mixed-citation">Daubin C, Parienti JJ, Vabret A, Ramakers M, Fradin S, Terzi N, Freymuth F, Charbonneau P, du Cheyron D. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. <span><span class="ref-journal">BMC Infect Dis. </span>2008;<span class="ref-vol">8</span>:145. doi: 10.1186/1471-2334-8-145.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2577677/">PMC free article</a>]</span> [<a href="/pubmed/18947382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1471-2334-8-145" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Infect+Dis&amp;title=Procalcitonin+levels+in+acute+exacerbation+of+COPD+admitted+in+ICU:+a+prospective+cohort+study&amp;author=C+Daubin&amp;author=JJ+Parienti&amp;author=A+Vabret&amp;author=M+Ramakers&amp;author=S+Fradin&amp;volume=8&amp;publication_year=2008&amp;pages=145&amp;pmid=18947382&amp;doi=10.1186/1471-2334-8-145&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="mixed-citation">Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. <span><span class="ref-journal">N Engl J Med. </span>1997;<span class="ref-vol">336</span>:243\xe2\x80\x9350. doi: 10.1056/NEJM199701233360402.</span> [<a href="/pubmed/8995086" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJM199701233360402" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+prediction+rule+to+identify+low-risk+patients+with+community-acquired+pneumonia&amp;author=MJ+Fine&amp;author=TE+Auble&amp;author=DM+Yealy&amp;author=BH+Hanusa&amp;author=LA+Weissfeld&amp;volume=336&amp;publication_year=1997&amp;pages=243-50&amp;pmid=8995086&amp;doi=10.1056/NEJM199701233360402&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="mixed-citation">Daubin C, Vincent S, Vabret A, du Cheyron D, Parienti JJ, Ramakers M, Freymuth F, Charbonneau P. Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. <span><span class="ref-journal">Intensive Care Med. </span>2005;<span class="ref-vol">31</span>:1116\xe2\x80\x931122. doi: 10.1007/s00134-005-2706-1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7079837/">PMC free article</a>]</span> [<a href="/pubmed/15999253" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00134-005-2706-1" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=Nosocomial+viral+ventilator-associated+pneumonia+in+the+intensive+care+unit:+a+prospective+cohort+study&amp;author=C+Daubin&amp;author=S+Vincent&amp;author=A+Vabret&amp;author=D+du+Cheyron&amp;author=JJ+Parienti&amp;volume=31&amp;publication_year=2005&amp;pages=1116-1122&amp;pmid=15999253&amp;doi=10.1007/s00134-005-2706-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="mixed-citation">Bellau-Pujol S, Vabret A, Legrand L, Dina J, Gouarin S, Petitjean-Lecherbonnier, Pozzetto B, Ginevra C, Freymuth F. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. <span><span class="ref-journal">J Virol Methods. </span>2005;<span class="ref-vol">126</span>:53\xe2\x80\x9363. doi: 10.1016/j.jviromet.2005.01.020.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112904/">PMC free article</a>]</span> [<a href="/pubmed/15847919" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jviromet.2005.01.020" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Development+of+three+multiplex+RT-PCR+assays+for+the+detection+of+12+respiratory+RNA+viruses&amp;author=S+Bellau-Pujol&amp;author=A+Vabret&amp;author=L+Legrand&amp;author=J+Dina&amp;author=S+Gouarin&amp;volume=126&amp;publication_year=2005&amp;pages=53-63&amp;pmid=15847919&amp;doi=10.1016/j.jviromet.2005.01.020&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="mixed-citation">Freymuth F, Vabret A, Rozenberg F, Dina J, Petitjean J, Gouarin S, Legrand L, Corbet S, Brouard J, Lebon P. Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line. <span><span class="ref-journal">Med Virol. </span>2005;<span class="ref-vol">77</span>:295\xe2\x80\x93301. doi: 10.1002/jmv.20449.</span> [<a href="/pubmed/16121382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fjmv.20449" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Virol&amp;title=Replication+of+respiratory+viruses,+particularly+influenza+virus,+rhinovirus,+and+coronavirus+in+HuH7+hepatocarcinoma+cell+line&amp;author=F+Freymuth&amp;author=A+Vabret&amp;author=F+Rozenberg&amp;author=J+Dina&amp;author=J+Petitjean&amp;volume=77&amp;publication_year=2005&amp;pages=295-301&amp;doi=10.1002/jmv.20449&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="mixed-citation">Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. <span><span class="ref-journal">Mayo Clin Proc. </span>1975;<span class="ref-vol">50</span>:339\xe2\x80\x93344.</span> [<a href="/pubmed/1127999" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mayo+Clin+Proc&amp;title=Microscopic+and+bacteriologic+analysis+of+expectorated+sputum&amp;author=PR+Murray&amp;author=JA+Washington&amp;volume=50&amp;publication_year=1975&amp;pages=339-344&amp;pmid=1127999&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="mixed-citation">Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>1998;<span class="ref-vol">157</span>:1498\xe2\x80\x93505.</span> [<a href="/pubmed/9603129" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Bronchial+microbial+patterns+in+severe+exacerbations+of+chronic+obstructive+pulmonary+disease+(COPD)+requiring+mechanical+ventilation&amp;author=N+Soler&amp;author=A+Torres&amp;author=S+Ewig&amp;author=J+Gonzalez&amp;author=R+Celis&amp;volume=157&amp;publication_year=1998&amp;pages=1498-505&amp;pmid=9603129&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="mixed-citation">Leroy O, Bosquet C, Vandenbussche C, Coffinier C, Georges H, Guery B, Alfandary S, Thevenin D, Beaucaire G. Community-Acquired Pneumonia in the Intensive Care Unit: Epidemiological and prognosis data in Older People. <span><span class="ref-journal">J Am Geriart Soc. </span>1999;<span class="ref-vol">47</span>:539\xe2\x80\x93546.</span> [<a href="/pubmed/10323646" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Geriart+Soc&amp;title=Community-Acquired+Pneumonia+in+the+Intensive+Care+Unit:+Epidemiological+and+prognosis+data+in+Older+People&amp;author=O+Leroy&amp;author=C+Bosquet&amp;author=C+Vandenbussche&amp;author=C+Coffinier&amp;author=H+Georges&amp;volume=47&amp;publication_year=1999&amp;pages=539-546&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="mixed-citation">Nylen E, Muller B, Becker KL, Snider R. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. <span><span class="ref-journal">Clin Infect Dis. </span>2003;<span class="ref-vol">36</span>:823\xe2\x80\x93824. doi: 10.1086/368088.</span> [<a href="/pubmed/12627371" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F368088" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=The+future+diagnostic+role+of+procalcitonin+levels:+the+need+for+improved+sensitivity&amp;author=E+Nylen&amp;author=B+Muller&amp;author=KL+Becker&amp;author=R+Snider&amp;volume=36&amp;publication_year=2003&amp;pages=823-824&amp;pmid=12627371&amp;doi=10.1086/368088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="mixed-citation">Masi&#x000e1; M, Guti&#x000e9;rrez F, Shum C, Padilla S, Navarro JC, Flores E, Hern&#x000e1;ndez I. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. <span><span class="ref-journal">Chest. </span>2005;<span class="ref-vol">128</span>:2223\xe2\x80\x939. doi: 10.1378/chest.128.4.2223.</span> [<a href="/pubmed/16236878" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1378%2Fchest.128.4.2223" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Usefulness+of+procalcitonin+levels+in+community-acquired+pneumonia+according+to+the+patients+outcome+research+team+pneumonia+severity+index&amp;author=M+Masi&#x000e1;&amp;author=F+Guti&#x000e9;rrez&amp;author=C+Shum&amp;author=S+Padilla&amp;author=JC+Navarro&amp;volume=128&amp;publication_year=2005&amp;pages=2223-9&amp;pmid=16236878&amp;doi=10.1378/chest.128.4.2223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2754485&amp;issue-id=175846&amp;journal-id=36&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">BMC Infectious Diseases</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2754485/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2754485/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2754485/pdf/1471-2334-9-157.pdf">PDF (273K)</a></li> | <li><a href="#" data-citationid="PMC2754485" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2754485%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2754485%2F&amp;text=Procalcitonin%20levels%20and%20bacterial%20aetiology%20among%20COPD%20patients%20admitted%20to%20the%20ICU%20with%20severe%20pneumonia%3A%20a%20prospective%20cohort%20study"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2754485%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19772586" data-aiid="2754485" data-aid="2754485" data-iid="175846" data-domainid="36" data-domain="bmcid" data-accid="PMC2754485" data-md5="75dda9bce8f3d18ef2f6505b47d822b6"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:24:26-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BA93FE9A3AF210000000004FC04FA&amp;ncbi_session=8A1BA93FE9A48B91_1276SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2754485%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=bmcid&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2754485/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BA93FE9A48B91_1276SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'